Maternal serum analytes such as pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF), which have already been used in the screening of preeclampsia and been proven to be associated with APOs, were also available in the first trimester [14–16]. Here, PGF is linked to preeclampsia.